uniQure Announces Company Presentation at Jefferies Healthcare Conference
June 01 2017 - 7:00AM
uniQure N.V. (NASDAQ:QURE), a leading gene therapy company
advancing transformative therapies for patients with severe medical
needs, today announced that it will present a corporate overview
and host investor meetings during the Jefferies Healthcare
Conference, held in New York City, from June 6 - 9, 2017.
Matt Kapusta, chief executive officer, will
present on Friday, June 9, 2017 at 8:00 am EDT. The live
webcast of the presentation can be accessed through the link
displayed in the Investor Section of uniQure website
at http://uniqure.com/investors-newsroom/events-presentations.php.
A replay of the webcast will be available within 24 hours following
the event, and will remain available for at least two weeks.
About uniQure uniQure is
delivering on the promise of gene therapy – single treatments with
potentially curative results. We are leveraging our modular and
validated technology platform to rapidly advance a pipeline of
proprietary and partnered gene therapies to treat patients with
hemophilia, Huntington’s disease and cardiovascular diseases.
www.uniQure.com
uniQure Contacts:
Maria E. Cantor
Direct: 339-970-7536
Mobile: 617-680-9452
m.cantor@uniQure.com
Tom Malone
Direct: 339-970-7558
Mobile: 339-223-8541
t.malone@uniQure.com
Eva M. Mulder
Direct: +31 20 240 6103
Mobile: +31 6 52 33 15 79
e.mulder@uniQure.com
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jun 2024 to Jul 2024
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jul 2023 to Jul 2024